DCF — GOOD SAMARITAN MEDICAL CENTER
Enterprise Value: $172.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$172.2M
Enterprise Value
$43.0M
PV of Cash Flows
$129.1M
PV of Terminal Value
$208.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $309.2M | $24.4M | 8.0% | $7.1M | $6.5M |
| Year 2 | $318.5M | $28.3M | 9.0% | $9.7M | $8.1M |
| Year 3 | $328.0M | $32.4M | 10.0% | $12.5M | $9.4M |
| Year 4 | $337.9M | $35.1M | 10.0% | $14.1M | $9.7M |
| Year 5 | $348.0M | $37.0M | 11.0% | $15.2M | $9.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $172.2M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$300.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07390348101542012
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5